You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Aug 16, 2025

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
Lillian Li1, John V Wilkins2, Amir R Esmaeili2
1Vaccine CMC Development & Supply, Sanofi, Toronto, Room 121, Building 95, Sanofi, 1755 Steeles Avenue West, Toronto, ON, M2R 3T4, USA. lillian.li@Sanofi.com.
This study evaluated intranasal vaccine delivery devices for infants, finding they consistently achieved over 80% delivery efficiency to nasal airways. Spray characteristics and nozzle distance significantly impacted vaccine deposition in infant nasal models.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: